Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria-Reference-Cited by-同舟云学术

Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria

Published:2022 Issue:1 Volume:25 Page:97
ISSN:1119-3077
Container-title:Nigerian Journal of Clinical Practice
language:en
Short-container-title:Niger J Clin Pract

Author:

Liman AA,Kabir B,Abubakar M,Abdullahi S,Ahmed SA,Shehu SM

Publisher

Medknow

Subject

General Medicine

Reference42 articles.

1. International Agency for Research on Cancer. The Global Cancer Observatory, Geneva: World Health Organization; 2019. Availablefrom: gco.iarc.fr/today/data/factsheets/populations/566-nigeria-fact-sheets.pdf. [Last accessed on 2020 Jun 23].

2. Molecular portraits of human breast tumors;Perou;Nature,2000

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sørlie;Proc Natl Acad Sci USA,2001

4. Triple-negative breast;Foulkes;N Eng J Med,2010

5. Triple negative breast cancer: Current and emerging concepts;Schmadeka;Am J Clin Pathol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review;Technology in Cancer Research & Treatment;2023-01

2. Comparison of the Efficacy and Safety of Ponatinib and Dasatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia With Central Nervous System Relapse: A Retrospective Study;Technology in Cancer Research & Treatment;2023-01

3. Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer;Cancers;2022-12-30